To ask the Scottish Executive what the total expenditure was on medical research into the causes and methods of diagnosis or treatment of (a) autism or Asperger’s syndrome, (b) dyspraxia or developmental co-ordination disorder, (c) attention deficit hyperactivity disorder, (d) Tourette’s syndrome, (e) dyslexia, (f) deficit in attention, motor control and perception and (g) any other recognised learning difficulties or learning disabilities in each of the last five years.
The Chief Scientist Office (CSO), of the Scottish Government''s Health Directorates, has responsibility for encouraging and supporting research into health and health care needs in Scotland. The main agency through which the UK Government funds medical and clinical research is the Medical Research Council (MRC).
Total direct expenditure by the CSO and the MRC on (a) autism or Asperger''s syndrome research in each of the last five years was as follows:
| CSO | MRC |
2003-04 | £43,700 | £1.2 million |
2004-05 | £201,000 | £1.0 million |
2005-06 | £133,500 | £1.1 million |
2006-07 | £143,700 | £1.7 million |
2007-08 | £139,800 | £2.3 million |
There was no direct expenditure by the CSO or the MRC on (b) dyspraxia research in the last five years.
There was no direct expenditure by the CSO on (c) attention deficit hyperactivity disorder (ADHD) research in the last five years. Total direct expenditure by the MRC on ADHD research in each of the last five years was as follows:
2003-04 | £262,000 |
2004-05 | £480,000 |
2005-06 | £380,000 |
2006-07 | £594,000 |
2007-08 | £294,000 |
There was no direct expenditure by the CSO or the MRC on (d) Tourette''s syndrome research in the last five years.
Total direct expenditure by the CSO and the MRC on (e) dyslexia research in each of the last five years was as follows:-
| CSO | MRC |
2003-04 | £4,000 | £296,000 |
2004-05 | £0 | £296,000 |
2005-06 | £0 | £434,000 |
2006-07 | £37,200 | £377,000 |
2007-08 | £0 | £330,000 |
There was no direct expenditure by the CSO or the MRC on (f) deficit in attention, motor control and perception research in the last five years.
Total direct expenditure by the CSO and the MRC on (g) other recognised learning difficulties or learning disabilities research including learning difficulties/disabilities more generally in the last five years was as follows:
| CSO | MRC |
2003-04 | £224,600 | £1.5 million |
2004-05 | £299,100 | £1.5 million |
2005-06 | £282,300 | £1.9 million |
2006-07 | £91,200 | £2.1 million |
2007-08 | £15,200 | £2.2 million |
Expenditure made by research charities on these conditions is not held centrally.
In addition to direct research expenditure, the CSO also meets the additional indirect costs to the NHS of hosting research funded by bodies such as the MRC and research charities. Such indirect expenditure on these conditions is not held centrally.